KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.1855
-0.0053 (-2.78%)
At close: Oct 22, 2026, 4:00 PM EDT
0.1900
+0.0045 (2.43%)
Pre-market: Oct 23, 2026, 4:41 AM EDT
KALA BIO Market Cap
KALA BIO has a market cap or net worth of $3.59 million as of October 22, 2026. It is the 46,176th most valuable company in the world and the 6,154th biggest in the United States. Its market cap has decreased by 44.81% in one year.
Market Cap
3.59M
Enterprise Value
-3.64M
1-Year Change
-44.81%
Global Rank
Country Rank
#6,154 United States
Category
ChartMarket Cap Chart
Since July 20, 2017, KALA BIO's market cap has decreased from $430.50M to $3.59M, a decrease of -99.17%. That is a compound annual growth rate of -40.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 3.60M | -21.74% |
| Dec 31, 2025 | 4.60M | -85.63% |
| Dec 31, 2024 | 32.00M | 69.31% |
| Dec 29, 2023 | 18.90M | -67.36% |
| Dec 30, 2022 | 57.90M | -26.99% |
| Dec 31, 2021 | 79.30M | -79.14% |
| Dec 31, 2020 | 380.20M | 198.20% |
| Dec 31, 2019 | 127.50M | -22.87% |
| Dec 31, 2018 | 165.30M | -63.54% |
| Dec 29, 2017 | 453.40M | 5.32% |
| Jul 20, 2017 | 430.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Azitra | 4.33M |
| Lexaria Bioscience | 4.30M |
| NuCana | 4.21M |
| Liminatus Pharma | 4.18M |
| Enlivex | 4.13M |
| Cadrenal Therapeutics | 3.78M |
| PharmaCyte Biotech | 3.67M |
| Jupiter Neurosciences | 3.63M |